FDA Inspection 1167657 — Fagron Compounding Services

Fagron Compounding Services — FEI 3012104093

The FDA completed an inspection of Fagron Compounding Services on March 24, 2022 in Wichita, KS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 24, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wichita, KS (United States)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
143521 CFR 211.42(c)(10)(v)Cleaning System
181021 CFR 211.160(a)Lab controls established, including changes
188321 CFR 211.165(a)Testing and release for distribution
358321 CFR 211.110(a)Written in-process control procedures